乙胺碘呋酮(Amiodrone)有选择性扩张血管平滑肌,增加冠状动脉血流量,减少心肌氧耗量的作用。最初用于治疗冠心病心绞痛,近年来用于治疗室上性及室性心律失常,具有强烈的抗颤动作用,服药时间稍长,可出现角膜色素沉着,国内外文献已有报导。我们随访8例口期本药患者,现将其中1例色素沉着较重者报告如下。患者刘××男 51岁于1980年6月初因患心房纤颤按乙胺碘呋酮常规服药。初量每日600mg共15天,以后逐渐减量至每日200mg,每周 Amiodrone selectively expands vascular smooth muscle, increases coronary blood flow and reduces myocardial oxygen consumption. Initially used for the treatment of angina pectoris, in recent years for the treatment of supraventricular and ventricular arrhythmias, has a strong anti-fibrillation, taking a longer time, there may be corneal pigmentation, literature has been reported at home and abroad. We followed up 8 cases of oral drug patients, now one of the cases of hyperpigmentation were reported as follows. Liu XX male patient 51 years old in early June 1980 due to atrial fibrillation by amiodarone routine medication. The initial amount of 600mg daily for 15 days, after gradual reduction to 200mg daily, weekly